Log in

IOL Chemicals and Pharmaceuticals

NSE: IOLCP · ISIN INE485C01029 · Healthcare

₹207.20+22.91 (+12.43%)

Monday 9 November, 12:18 IST. Delayed. Source: Yahoo Finance.

Price chart

₹207.20 +22.91 (+12.43%) today

The day

Previous close
₹184.29
Open
₹185.49
Day high
₹214.85
Day low
₹184.10

Listed on NSE since 8 November 2010.

Key numbers

Market value
₹6,081.89 Cr
P/E (trailing)
30.12
EPS (trailing)
₹6.88
Price to book
3.15
Dividend yield
0.54%
Return on equity
11.1%
Debt to equity
0.10
Profit margin
7.4%
Beta
0.55
Volume today
2.25 Cr
Average volume
38.40 L

Source: Yahoo Finance. Ratios use the latest reported (trailing twelve-month) figures.

Revenue and profit

Annual revenue and profit
YearRevenueNet profitEPS
FY23₹2,201.69 Cr₹139.14 Cr₹4.74
FY24₹2,118.96 Cr₹134.43 Cr₹4.58
FY25₹2,068.19 Cr₹101.07 Cr₹3.44
FY26₹2,307.81 Cr₹137.64 Cr₹4.69

Source: Yahoo Finance, from annual reports. Consolidated where reported.

Quarterly results

Results for each quarter, latest first
QuarterRevenueNet profitEPSProfit vs year ago
Q2 FY27Jul–Sep 2026₹795 Cr₹65 Cr₹2.21+117.1%
Q1 FY27Apr–Jun 2026₹756 Cr₹64 Cr₹2.20+89.8%
Q4 FY26Jan–Mar 2026₹619 Cr₹53 Cr₹1.81+69.2%
Q3 FY26Oct–Dec 2025₹580 Cr₹21 Cr₹0.70–
Q2 FY26Jul–Sep 2025₹568 Cr₹30 Cr₹1.02–
Q1 FY26Apr–Jun 2025₹552 Cr₹34 Cr₹1.16–

Source: IOL Chemicals and Pharmaceuticals’s results filed with NSE, consolidated (the whole group). Net profit is the share of IOL Chemicals and Pharmaceuticals’s own shareholders where the filing separates it. Profit vs year ago compares with the same quarter a year earlier; – where that quarter is not on file or made a loss.

Download results (zip) A spreadsheet of the quarterly results and balance sheets, with the original filings from NSE.

Balance sheet

What the company owns and owes, latest first
As onSeptember 2026March 2026September 2025
Fixed assets₹1,360 Cr₹1,259 Cr₹1,193 Cr
Investments₹21 Cr₹21 Cr₹21 Cr
Inventories₹464 Cr₹371 Cr₹384 Cr
Owed by customers₹689 Cr₹603 Cr₹523 Cr
Cash and equivalents₹9 Cr₹65 Cr₹27 Cr
Total assets₹2,831 Cr₹2,587 Cr₹2,413 Cr
Borrowings₹194 Cr₹132 Cr₹159 Cr
Total liabilities₹905 Cr₹788 Cr₹662 Cr
Shareholders’ equity₹1,926 Cr₹1,799 Cr₹1,751 Cr

Source: IOL Chemicals and Pharmaceuticals’s half-yearly statements of assets and liabilities filed with NSE, consolidated. Companies file these every September and March.

About IOL Chemicals and Pharmaceuticals

IOL Chemicals and Pharmaceuticals Limited manufactures and sells pharmaceutical and chemical products in India and internationally. It operates through two segments: Pharmaceuticals and Specialty Chemicals. The Chemical segment offers ethyl acetate, iso butyl benzene, acetyl chloride, mono chloro acetic acid, and acetic anhydride to the food processing, flexible packaging, pharmaceuticals, textiles, ink, paint, plasticizers and ploymers, and chemical intermediates industries. The Pharmaceutical segment provides active pharmaceutical ingredients, such as ibuprofen, metformin, fenofibrate, lamotrigine, clopidogrel bisulphate, pantoprazole sodium, ursodeoxycholic acid, losartan potassium, gabapentin, levetiracetam, and paracetamol. Its active pharmaceutical ingredients are used for the treatment of anti-inflammatory, analgesic and antipyretic, anti-diabetic, antiplatelet, anti-cholesterol, anti-convulsant, anti-epileptic, anti-hypertensive, and anti-cholelithic, as well as proton pump inhibitor. IOL Chemicals and Pharmaceuticals Limited was incorporated in 1986 and is based in Ludhiana, India.

Industry
Drug Manufacturers - Specialty & Generic
Based in
Ludhiana
Employees
3,095

Company website · Profile: Yahoo Finance

In the news

All news

No headlines name IOL Chemicals and Pharmaceuticals in the last day or two.

Dividends and corporate actions

All companies
  • Interim Dividend - Re 1 Per Share

    Dividend · ex-date 17 February 2026

  • Face Value Split (Sub-Division) - From Rs 10/- Per Share To Rs 2/- Per Share

    Split · ex-date 11 March 2025

  • Interim Dividend - Rs 4 Per Share

    Dividend · ex-date 18 February 2025

  • Annual General Meeting

    Action · ex-date 16 August 2024

  • Interim Dividend - Rs 5 Per Share

    Dividend · ex-date 16 February 2024

  • Annual General Meeting

    Action · ex-date 3 August 2023

  • Interim Dividend - Rs 4 Per Share

    Dividend · ex-date 17 February 2023

  • Annual General Meeting

    Action · ex-date 18 August 2022

Source: NSE. Latest first, 8 of 20.

Information only, not investment advice. Prices are delayed.

ShareWhatsAppTelegram

Open inZerodha ↗Groww ↗Angel One ↗For convenience only: no referral, not a recommendation.